The Doctor Might Prescribe This Biotech Before Wall Street Does

One tiny biotech just revealed clinical results that could change how doctors fight superbugs.

With Phase 3 now in sight, the question isn’t whether it works: it’s how fast the market will catch on.

Why settle for decent gains when you could aim for transformational ones?

Our research team just finished analyzing thousands of companies — and narrowed them down to 5 stocks with the highest potential to gain +100% or more over the next 12 months.

These aren’t random picks or hype stocks.

While no strategy can guarantee results, past editions of this report have uncovered stocks that went on to post exceptional returns — some soaring triple digits in a single cycle.

If you want to see which 5 names made the cut, you can download the full report today — absolutely free.

But act fast: this opportunity is only available until MIDNIGHT TONIGHT.

[Get Your Free Report Now]

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

U.S. stocks declined as renewed U.S.-China trade tensions and Netflix’s disappointing margin results weighed on investor sentiment ahead of key tech earnings and inflation data.

General Motors (NYSE: GM) is rolling out its boldest plan yet to reinvent driving for the digital age.

You’ll soon be able to talk, navigate, and plan directly with your car as Google’s Gemini AI system becomes the brain of future GM vehicles.

The company isn’t just adding features; it’s creating a new kind of driving experience.

Your dashboard will double as a smart assistant that learns your routes, preferences, and habits over time.

Turning Cars Into Computers on Wheels

GM’s long-term vision blends AI, automation, and integrated software to build cars that update like phones.

You’ll see faster upgrades, better safety systems, and fewer maintenance delays thanks to its unified computing platform.

The company’s goal is to make driving more connected, efficient, and personal while unlocking new revenue from digital services.

For an industry built on horsepower, this new model runs on data and design.

The Real Test Drive Starts Now

GM’s next challenge is turning big tech ambition into tangible results.

The company’s success will depend on execution, speed, and quickly winning your trust in the age of intelligent mobility.

If it gets this right, your next GM could be less of a car and more of a co-pilot built to understand you.

Coca-Cola (NYSE: KO) continues to hold its place as one of the most reliable performers in consumer goods.

You can see the momentum building as demand remains steady across every major region, from Asia to North America.

The company’s last quarter showed strength in both revenue and profit margins.

That mix of steady volume and smart pricing has turned into a powerful growth engine that few rivals can match.

Results That Keep Pouring In

If you care about income, Coca-Cola keeps delivering.

The company has raised its dividend for more than six decades, giving you a payout stream that’s as predictable as its red label on store shelves.

It also continues to buy back shares, quietly trimming supply while keeping confidence high.

You can think of it as the classic case of a company doing the small things right for the long haul.

The Real Sparkle Ahead

Coca-Cola’s next chapter could be written in new highs as analysts stay bullish and institutional money keeps flowing in.

The stock’s momentum and its reputation for resilience make it one to watch before the next run begins.

If you’re looking for stability wrapped in global appeal, Coca-Cola may be the kind of slow-burn story you’ll be glad you didn’t overlook.

Crypto history was made — and most people missed it.

Congress just passed the GENIUS Act, the first major crypto law in U.S. history. Trump signed it immediately, calling America the “crypto capital of the planet.”

This law changes everything.

For the first time, crypto has federal clarity — not case-by-case enforcement.

That means:

Get your FREE Crypto Revolution book and see how to position yourself early — includes $788 in bonuses (just cover s&h).

Claim your copy now.

The regulatory revolution has begun.

© 2025 Boardwalk Flock LLC. All Rights Reserved. 2382 Camino Vida Roble, Suite I Carlsbad, CA 92011, United States

The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Readers acknowledge that the authors are not engaging in the rendering of legal, financial, medical, or professional advice. The reader agrees that under no circumstances Boardwalk Flock, LLC is responsible for any losses, direct or indirect, which are incurred as a result of the use of the information contained within this, including, but not limited to, errors, omissions, or inaccuracies.

Results may not be typical and may vary from person to person. Making money trading digital currencies takes time and hard work. There are inherent risks involved with investing, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk.

Apollo Global Management (NYSE: APO) is considering selling Heritage Grocers Group, a major U.S. supermarket chain serving Latino communities.

You’ve likely seen the brand’s growing presence across key states, blending local flavor with big-box efficiency.

The potential $1.5 billion deal shows how private equity is rethinking exposure to niche consumer markets.

You can feel the shift as demographic trends and politics start steering investment decisions as much as profit forecasts.

When Community Meets Capital

For Apollo, Heritage represented more than just a retail investment—it was an investment in identity and the spending power of the community.

The company’s loyal customer base made it resilient, but new economic pressures and immigration concerns are changing buying habits faster than expected.

If you’ve noticed tighter budgets and fewer trips to specialty stores, you’re not alone.

Those shifts are exactly what’s making investors second-guess long-term retail growth stories tied to cultural niches.

The Price Tag on Trust

A potential sale would send ripples through the private equity world, setting a fresh benchmark for community-driven retail valuations.

The bigger question is whether anyone else is ready to buy into that same model.

In a market where sentiment moves as fast as policy, adaptability might be worth more than brand loyalty.

👉 Click here to get our closing report to your cell for free!

Armata Pharmaceuticals Inc [ARMP] $6.81 (+96.25%)

Armata Pharmaceuticals jumped after presenting successful Phase 2a results at IDWeek, showing IV phage therapy significantly improved outcomes in patients with complicated Staphylococcus aureus infections.

Applied Dna Sciences Inc [BNBX] $4.80 (+40.35%)

Applied DNA soared over 50% after completing a $27 million PIPE financing and revealing multimillion-dollar BNB token purchases as part of a crypto-yield treasury strategy.

Vicor Corp [VICR] $85.75 (+30.32%)

Vicor shares rallied after beating Q3 earnings expectations and securing a major analyst upgrade, citing strong licensing growth and AI-related power delivery tech.

Arcturus Therapeutics Ltd [ARCT] $11.54 (-50.17%)

Arcturus plunged after its cystic fibrosis drug failed to show meaningful improvements in lung function during a key mid-stage trial.

Hut 8 Corp [HUT] $38.84 (-17.22%)

Hut 8 tumbled alongside a broad sell-off in Bitcoin miners as crypto stocks faced profit-taking and market-wide pressure.

Oklo Inc [OKLO] $120.02 (-13.93%)

Oklo declined for a third straight day following ARK Invest’s stake reduction and warnings from analysts and Jim Cramer about the risks of its hype-driven rally.

Every month, a handful of stocks quietly outperform the rest — and those early movers often go on to deliver double-digit gains.

We’ve identified 7 of them showing the strongest near-term potential based on proprietary screening signals.

These aren’t hype stocks or risky bets.

They’re backed by real earnings power, rising analyst sentiment, and technical strength — the kind of combination that precedes powerful rallies.

See which stocks are poised to lead the market higher over the next 30 days.

Get your free copy of this month’s 7 Market Winners.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.